SEC ownership of SPRUCE BIOSCIENCES, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001683553.

Comparable stake leader

Orin Hirschman

Disclosed value leader

Orin Hirschman

Comparable rows

38/50

Latest evidence

27 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
38 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Orin Hirschman
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
27 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001683553
Issuer location
South San Francisco, CA

Ownership snapshot

Top shareholders of SPRUCE BIOSCIENCES, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Orin Hirschman
Disclosed value leader
Orin Hirschman
Comparable rows
38/50
Latest evidence
27 Jul 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.1% 12 rows are not safely comparable across share classes. 13D/G row: Orin Hirschman Showing 1-8 of 50 holder rows.

Quick read

Orin Hirschman leads the comparable SEC ownership view at 9.1%.

38 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Orin Hirschman's linked filing trail.
Comparable ownership Top 5
Orin Hirschman 9.1%
BlackRock, Inc. 6.8%
Boone Peter David Mr 6.4%
INTEGRATED CORE STRATEGIES (US) LLC 5.8%
ADAR1 Capital Management, LLC 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Orin Hirschman
13D/G
9.1%
$13,500,000
250,000 shares
$0 30 Jun 2026
BlackRock, Inc.
13D/G 13F
Company
6.8%
$10,143,144
187,836 shares
$0 30 Jun 2026
Boone Peter David Mr
13D/G
6.4%
$8,045,712
68,184 shares
$0 21 Nov 2025
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
5.8%
$7,788,261
160,981 shares
+$2,803,863 30 Jun 2026
ADAR1 Capital Management, LLC
13D/G 13F
Company
5.4%
$4,796,020
58,000 shares
$0 31 Dec 2025
CITADEL ADVISORS LLC
13F 13D/G
Company · Kenneth Griffin
5.1%
from 13D/G
$4,574,435
69,999 shares
31 Mar 2026
Ikarian Capital, LLC
13F 13D/G
Company
4.8%
from 13D/G
$7,930,614
121,356 shares
31 Mar 2026
Carlyle Group Inc.
13D/G 13F
The Carlyle Group Inc. · Company
4.7%
$4,208,342
50,893 shares
$0 18 Feb 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$8,298.

Buys
$9,170
Insiders: 1
Sells
$873
Insiders: 1
Net
+$8,298
Shares: +462
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 512 Shares: 50
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 512 50 $9,170 $873 +$8,298

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-19 of 19 reporting-owner rows connected to SPRUCE BIOSCIENCES, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
19
Largest Forms 3/4/5 holder
Novo Holdings A/S
Net 12M change
+$8,298
Latest report
27 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Novo Holdings A/S 10%+ Owner $1,924,485 Filing P/S 21 Mar 2024
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER, Director $1,426,837 Mixed 30 Jun 2026
Samir M. Gharib President And Cfo $695,534 Mixed 15 Dec 2025
Douglas Kirk Ways Interim Chief Medical Officer, Director $91,912 Mixed 11 Dec 2025
Ralph William Charlton III Chief Medical Officer $87,394 Mixed 10 Dec 2024
Subaweerage Dias Chief Medical Officer $33,200 Mixed 16 Dec 2021
Parkman Healthcare Partners LLC 10%+ Owner $18,328 +$8,298 +83% Filing P/S 06 Oct 2025
Richard King Chief Executive Officer, Director $2,180 Mixed 30 Jun 2021
Camilla Simpson V Director Mixed 21 May 2026
Corwin Dale Hooks Chief Commercial Officer Mixed 09 Mar 2026
Moghrabi Dina Chaya Director Mixed 25 May 2022
Adrian W. Quartel Chief Medical Officer Mixed 27 Jul 2026
Tiba Aynechi Director Mixed 22 Jul 2025
Keli Walbert Director Mixed 21 May 2026
Michael G. Grey Executive Chairman, Director Mixed 21 May 2026
Niall O'Donnell Director Mixed 25 May 2023
Bali Muralidhar Director Mixed 22 Jul 2025
Percival Barretto-Ko Director Mixed 21 May 2026
Daniel K. Spiegelman Director Mixed 21 May 2026

Recent insider transactions for SPRUCE BIOSCIENCES, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Adrian W. Quartel SPRB Restricted Stock Units Award 13,000 13,000 27 Jul 2026 Direct
Javier B. Szwarcberg SPRB Common Stock Award 1.4% 266 19,270 30 Jun 2026 Direct
Daniel K. Spiegelman SPRB Stock Option (Right to Buy) Award 1,700 1,700 21 May 2026 Direct
Camilla Simpson V SPRB Stock Option (Right to Buy) Award 1,700 1,700 21 May 2026 Direct
Michael G. Grey SPRB Stock Option (Right to Buy) Award 1,700 1,700 21 May 2026 Direct
Percival Barretto-Ko SPRB Stock Option (Right to Buy) Award 1,700 1,700 21 May 2026 Direct
Keli Walbert SPRB Stock Option (Right to Buy) Award 1,700 1,700 21 May 2026 Direct
Corwin Dale Hooks SPRB Restricted Stock Units Award 11,000 11,000 09 Mar 2026 Direct
Javier B. Szwarcberg SPRB Common Stock Award 32.8% 4,690 19,004 31 Dec 2025 Direct
Samir M. Gharib SPRB Common Stock Tax liability -4.36% -362 7,934 15 Dec 2025 Direct
Samir M. Gharib SPRB Common Stock Options Exercise 13.6% 1,009 8,447 15 Dec 2025 Direct
Samir M. Gharib SPRB Restricted Stock Units Options Exercise -67% -1,009 497 15 Dec 2025 Direct
Javier B. Szwarcberg SPRB Common Stock Tax liability -9.01% -1,360 13,726 15 Dec 2025 Direct
Javier B. Szwarcberg SPRB Common Stock Options Exercise 21.8% 2,676 14,922 15 Dec 2025 Direct
Javier B. Szwarcberg SPRB Restricted Stock Units Options Exercise -64.4% -2,676 1,480 15 Dec 2025 Direct
Kirk Ways SPRB Common Stock Options Exercise 1,250 1,250 11 Dec 2025 Direct
Kirk Ways SPRB Stock Option (Right to Buy) Disposed to Issuer -100% -666 0 11 Dec 2025 Direct
Kirk Ways SPRB Stock Option (Right to Buy) Award 666 400 11 Dec 2025 Direct
Kirk Ways SPRB Restricted Stock Units Options Exercise -25% -1,250 3,750 11 Dec 2025 Direct
Kirk Ways SPRB Restricted Stock Units Award 5,000 5,000 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Employee Stock Option (right to buy) Disposed to Issuer -100% -1,666 0 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Employee Stock Option (right to buy) Award 1,666 1,666 11 Dec 2025 Direct
Daniel K. Spiegelman SPRB Stock Option (Right to Buy) Disposed to Issuer -100% -946 0 11 Dec 2025 Direct
Daniel K. Spiegelman SPRB Stock Option (Right to Buy) Award 946 458 11 Dec 2025 Direct
Michael G. Grey SPRB Stock Option (Right to Buy) Disposed to Issuer -100% -4,340 0 11 Dec 2025 Direct
Michael G. Grey SPRB Stock Option (Right to Buy) Award 4,340 1,499 11 Dec 2025 Direct
Samir M. Gharib SPRB Stock Option (Right to Buy) Disposed to Issuer -100% -6,131 0 11 Dec 2025 Direct
Samir M. Gharib SPRB Stock Option (Right to Buy) Award 6,131 1,933 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Employee Stock Option (right to buy) Disposed to Issuer -100% -10,000 0 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Employee Stock Option (right to buy) Award 10,000 10,000 11 Dec 2025 Direct
Camilla Simpson V SPRB Stock Option (Right to Buy) Disposed to Issuer -100% -1,377 0 11 Dec 2025 Direct
Camilla Simpson V SPRB Stock Option (Right to Buy) Award 1,377 400 11 Dec 2025 Direct
Percival Barretto-Ko SPRB Stock Option (Right to Buy) Disposed to Issuer -100% -800 0 11 Dec 2025 Direct
Percival Barretto-Ko SPRB Stock Option (Right to Buy) Award 800 800 11 Dec 2025 Direct
Keli Walbert SPRB Stock Option (Right to Buy) Award 3,400 3,400 11 Dec 2025 Direct
Samir M. Gharib SPRB Common Stock Tax liability -8.2% -680 7,616 11 Dec 2025 Direct
Samir M. Gharib SPRB Common Stock Options Exercise 29.7% 1,900 8,296 11 Dec 2025 Direct
Samir M. Gharib SPRB Restricted Stock Units Options Exercise -25% -1,900 5,700 11 Dec 2025 Direct
Samir M. Gharib SPRB Restricted Stock Units Award 7,600 7,600 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Common Stock Tax liability -14.4% -2,194 12,998 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Common Stock Options Exercise 48.3% 4,950 15,192 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Restricted Stock Units Options Exercise -25% -4,950 14,850 11 Dec 2025 Direct
Javier B. Szwarcberg SPRB Restricted Stock Units Award 19,800 19,800 11 Dec 2025 Direct
Samir M. Gharib SPRB Common Stock Tax liability -2.8% -184 6,396 10 Dec 2025 Direct
Samir M. Gharib SPRB Common Stock Options Exercise 8.47% 514 6,580 10 Dec 2025 Direct
Samir M. Gharib SPRB Restricted Stock Units Options Exercise -25% -514 1,539 10 Dec 2025 Direct
Javier B. Szwarcberg SPRB Common Stock Tax liability -4.01% -428 10,242 10 Dec 2025 Direct
Javier B. Szwarcberg SPRB Common Stock Options Exercise 12.6% 1,196 10,670 10 Dec 2025 Direct
Javier B. Szwarcberg SPRB Restricted Stock Units Options Exercise -25% -1,196 3,588 10 Dec 2025 Direct
Samir M. Gharib SPRB Common Stock Tax liability -9.83% -661 6,066 20 Oct 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .